Pharmacological characterization of small-conductance Ca(2+)-activated K(+) channels stably expressed in HEK 293 cells.
Three genes encode the small-conductance Ca(2+)-activated K(+) channels (SK channels). We have stably expressed hSK1 and rSK2 in HEK 293 cells and addressed the pharmacology of these subtypes using whole-cell patch clamp recordings. The bee venom peptide apamin blocked hSK1 as well as rSK2 with IC(50) values of 3.3 nM and 83 pM, respectively. The pharmacological separation between the subtypes was even more prominent when applying the scorpion peptide blocker scyllatoxin, which blocked hSK1 with an IC(50) value of 80 nM and rSK2 at 287 pM. The potent small molecule blockers showed little differentiation between the channel subtypes. The bis-quinolinium cyclophane UCL 1684 blocked hSK1 with an IC(50) value of 762 pM and rSK2 at 364 pM. The antiseptic compound dequalinium chloride blocked hSK1 and rSK2 with IC(50) values of 444 nM and 162 nM, respectively. The nicotinic acetylcholine receptor antagonist d-tubocurarine was found to block hSK1 and rSK2 with IC(50) values of 27 microM and 17 microM when measured at +80 mV. The inhibition by d-tubocurarine was voltage-dependent with increasing affinities at more hyperpolarized potentials. The GABA(A) receptor antagonist bicuculline methiodide also blocked hSK1 and rSK2 in a voltage-dependent manner with IC(50) values of 15 and 25 microM when measured at +80 mV. In conclusion, the pharmacological separation between SK channel subtypes expressed in mammalian cells is too small to support the notion that the apamin-insensitive afterhyperpolarization of neurones is mediated by hSK1.
Strøbaek
D
D
NeuroSearch A/S, 93 Pederstrupvej, DK-2750 Ballerup, Denmark.
Jørgensen
T D
TD
Christophersen
P
P
Ahring
P K
PK
Olesen
S P
SP
D000595:Amino Acid Sequence; D001030:Apamin / Q000494:pharmacology; D001640:Bicuculline / Q000494:pharmacology; D002460:Cell Line; D003001:Cloning, Molecular; D004594:Electrophysiology; D018756:GABA Antagonists / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008969:Molecular Sequence Data; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D010957:Plasmids; D015221:Potassium Channels / Q000096:biosynthesis / Q000187:drug effects*; D024681:Potassium Channels, Calcium-Activated; D051640:Small-Conductance Calcium-Activated Potassium Channels; D014118:Toxins, Biological / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D018756:GABA Antagonists; C496894:KCNN1 protein, human; D003473:Neuromuscular Nondepolarizing Agents; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; D051640:Small-Conductance Calcium-Activated Potassium Channels; D014118:Toxins, Biological; D001030:Apamin; D014403:Tubocurarine; D001640:Bicuculline